BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 10482541)

  • 1. Repression of Epstein-Barr virus EBNA-1 gene transcription by pRb during restricted latency.
    Ruf IK; Sample J
    J Virol; 1999 Oct; 73(10):7943-51. PubMed ID: 10482541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon regulatory factor 7 is induced by Epstein-Barr virus latent membrane protein 1.
    Zhang L; Pagano JS
    J Virol; 2000 Feb; 74(3):1061-8. PubMed ID: 10627515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of EBNA-1 mRNA is regulated by cell cycle during Epstein-Barr virus type I latency.
    Davenport MG; Pagano JS
    J Virol; 1999 Apr; 73(4):3154-61. PubMed ID: 10074167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autorepression of Epstein-Barr virus nuclear antigen 1 expression by inhibition of pre-mRNA processing.
    Yoshioka M; Crum MM; Sample JT
    J Virol; 2008 Feb; 82(4):1679-87. PubMed ID: 18077719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-independent and -induced regulation of Epstein-Barr virus EBNA-1 gene transcription in Burkitt lymphoma.
    Nonkwelo C; Ruf IK; Sample J
    J Virol; 1997 Sep; 71(9):6887-97. PubMed ID: 9261415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 protein.
    Nonkwelo C; Skinner J; Bell A; Rickinson A; Sample J
    J Virol; 1996 Jan; 70(1):623-7. PubMed ID: 8523583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines.
    Schaefer BC; Strominger JL; Speck SH
    Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10565-9. PubMed ID: 7479841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Epstein-Barr virus EBNA-1 promoter Qp requires an initiator-like element.
    Nonkwelo C; Ruf IK; Sample J
    J Virol; 1997 Jan; 71(1):354-61. PubMed ID: 8985357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Epstein-Barr virus latency BamHI-Q promoter is positively regulated by STATs and Zta interference with JAK/STAT activation leads to loss of BamHI-Q promoter activity.
    Chen H; Lee JM; Wang Y; Huang DP; Ambinder RF; Hayward SD
    Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9339-44. PubMed ID: 10430944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unique Epstein-Barr virus (EBV) latent gene expression, EBNA promoter usage and EBNA promoter methylation status in chronic active EBV infection.
    Yoshioka M; Kikuta H; Ishiguro N; Ma X; Kobayashi K
    J Gen Virol; 2003 May; 84(Pt 5):1133-1140. PubMed ID: 12692278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus EBNA-LP and transcription regulation properties of pRB, p107 and p53 in transfection assays.
    Inman GJ; Farrell PJ
    J Gen Virol; 1995 Sep; 76 ( Pt 9)():2141-9. PubMed ID: 7561751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation of Epstein-Barr virus (EBV) latent gene expression in Burkitt lymphoma cells infected with a recombinant EBV strain.
    Trivedi P; Spinsanti P; Cuomo L; Volpe M; Takada K; Frati L; Faggioni A
    J Virol; 2001 May; 75(10):4929-35. PubMed ID: 11312367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutive activation of Epstein-Barr virus (EBV) nuclear antigen 1 gene transcription by IRF1 and IRF2 during restricted EBV latency.
    Schaefer BC; Paulson E; Strominger JL; Speck SH
    Mol Cell Biol; 1997 Feb; 17(2):873-86. PubMed ID: 9001242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reciprocal regulation of the Epstein-Barr virus BamHI-F promoter by EBNA-1 and an E2F transcription factor.
    Sung NS; Wilson J; Davenport M; Sista ND; Pagano JS
    Mol Cell Biol; 1994 Nov; 14(11):7144-52. PubMed ID: 7935429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human p32: a coactivator for Epstein-Barr virus nuclear antigen-1-mediated transcriptional activation and possible role in viral latent cycle DNA replication.
    Van Scoy S; Watakabe I; Krainer AR; Hearing J
    Virology; 2000 Sep; 275(1):145-57. PubMed ID: 11017796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon regulatory factor 2 represses the Epstein-Barr virus BamHI Q latency promoter in type III latency.
    Zhang L; Pagano JS
    Mol Cell Biol; 1999 Apr; 19(4):3216-23. PubMed ID: 10082588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic regulation of latent Epstein-Barr virus promoters.
    Takacs M; Banati F; Koroknai A; Segesdi J; Salamon D; Wolf H; Niller HH; Minarovits J
    Biochim Biophys Acta; 2010; 1799(3-4):228-35. PubMed ID: 19853674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms that regulate Epstein-Barr virus EBNA-1 gene transcription during restricted latency are conserved among lymphocryptoviruses of Old World primates.
    Ruf IK; Moghaddam A; Wang F; Sample J
    J Virol; 1999 Mar; 73(3):1980-9. PubMed ID: 9971778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1.
    Ling PD; Hsieh JJ; Ruf IK; Rawlins DR; Hayward SD
    J Virol; 1994 Sep; 68(9):5375-83. PubMed ID: 8057421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcription of Epstein-Barr virus-encoded nuclear antigen 1 promoter Qp is repressed by transforming growth factor-beta via Smad4 binding element in human BL cells.
    Liang CL; Tsai CN; Chung PJ; Chen JL; Sun CM; Chen RH; Hong JH; Chang YS
    Virology; 2000 Nov; 277(1):184-92. PubMed ID: 11062049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.